Propel Bio Management, LLC

Holdings History for Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

Symbol: APLT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 6,015,394 shares
Security Ownership %: 4.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Propel Bio Management, LLC ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)

31 Dec 2025 - Propel Bio Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,015,394 shares of Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT). This represents 4.2% ownership of the company. This is the first filing by Propel Bio Management, LLC disclosing ownership of Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Propel Bio Management, LLC	4.2%		$1,564,002	6,015,394			$0.2600	13G/A	29 Dec 2025	31 Dec 2025, 12:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	6.8%	0%	$6,826,551	11,285,420	0		$0.6049	Q3 2025
30 Jun 2025	4.3%	0%	$3,510,894	11,285,420	0		$0.3111	Q2 2025
31 Mar 2025	6.4%	+0.95%	$5,517,442	11,285,420	+1,670,000		$0.4889	Q1 2025
31 Dec 2024	8.2%	+2.6%	$8,232,723	9,615,420	+3,047,562	+46%	$0.8562	Q4 2024
30 Sep 2024	32%	0%	$55,826,793	6,567,858	0		$8.50	Q3 2024
30 Jun 2024	20%	+1.5%	$30,671,897	6,567,858	+455,952	+7.5%	$4.67	Q2 2024
31 Mar 2024	24%	+4.3%	$41,560,961	6,111,906	+736,924	+14%	$6.80	Q1 2024
31 Dec 2023	15%	0%	$18,006,190	5,374,982	0		$3.35	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.